Sélectionner une page

Christophe POQUET

Business Development Manager

R&D preclinical; Drug Discovery; Cell-based assays; Phenotypic screening; Target identification; lead compounds; drug candidates; muscular disorders

CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates.

CYOO has developed MyoScreen, a fully mature human in vitro muscle model derived from primary human samples (healthy and pathological myoblasts) for generating NCEs and identifying new targets from a variety of pathological conditions (rare, chronic).

CYTOO’s know-how and expertise portfolio include:
– patient cells sourcing and donor profiling;
– disease modeling;
– custom assay development (including expertise in image analysis);
– HCS and phenotypic screening.

Secondary focus on HCS- and HT compatible skin models (atopic dermatitis, psoriasis).